Cargando…

Supplementary Role of Immunological Indicators in the Diagnosis and Prognosis of Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients

BACKGROUND: Pneumocystis pneumonia (PCP) has a high mortality in HIV-negative immunocompromised patients. The occurrence and development of PCP are believed to be correlated with the level of lymphocytes and their subsets. The aim of this study was to determine if the levels of lymphocyte subpopulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yaoqian, Chen, Jiayue, Dong, Lixia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406888/ https://www.ncbi.nlm.nih.gov/pubmed/36034170 http://dx.doi.org/10.2147/IDR.S372427

Ejemplares similares

Using Routine Laboratory Markers and Immunological Indicators for Predicting Pneumocystis jiroveci Pneumonia in Immunocompromised Patients
por: Tang, Guoxing, et al.
Publicado: (2021)

Diagnosis of Pneumocystis jirovecii pneumonia with serum cell-free DNA in non-HIV-infected immunocompromised patients
por: Wang, Dong, et al.
Publicado: (2017)

Quantitative PCR to Discriminate Between Pneumocystis Pneumonia and Colonization in HIV and Non-HIV Immunocompromised Patients
por: Sarasombath, Patsharaporn T., et al.
Publicado: (2021)

Multiple nodular lesions following Pneumocystis pneumonia in a non‐HIV immunocompromised patient
por: Asakura, Takanori, et al.
Publicado: (2016)

Simultaneous bilateral pneumothorax in an immunocompromised HIV patient with Pneumocystis jirovecii pneumonia
por: Matesanz López, Cristina, et al.
Publicado: (2018)

Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection
por: Xue, Ting, et al.
Publicado: (2023)

Pneumocystis jirovecii dihydropteroate synthase gene mutations in a group of HIV-negative immunocompromised patients with Pneumocystis pneumonia
por: LONG, YINGJIAO, et al.
Publicado: (2014)

Colonization of Pneumocystis jirovecii in Chronic Obstructive Pulmonary Disease (COPD) patients and the rate of Pneumocystis pneumonia in Iranian non-HIV(+) immunocompromised patients
por: Sheikholeslami, Maryam Fatemeh, et al.
Publicado: (2013)

Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients
por: Ibrahim, Atif, et al.
Publicado: (2023)

Is It Possible to Differentiate Pneumocystis jirovecii Pneumonia and Colonization in the Immunocompromised Patients with Pneumonia?
por: Aguilar, Yudy A., et al.
Publicado: (2021)

A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
por: Rabacal, Whitney, et al.
Publicado: (2022)

Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients
por: Mu, Xiang-Dong, et al.
Publicado: (2016)

Pneumocystis Pneumonia in HIV-Infected and Immunocompromised Non-HIV Infected Patients: A Retrospective Study of Two Centers in China
por: Guo, Fei, et al.
Publicado: (2014)

Circulating and Pulmonary T-cell Populations Driving the Immune Response in Non-HIV Immunocompromised Patients with Pneumocystis jirovecii Pneumonia
por: Zhang, Nan-Nan, et al.
Publicado: (2019)

Characteristics and Prognostic Factors of Non-HIV Immunocompromised Patients With Pneumocystis Pneumonia Diagnosed by Metagenomics Next-Generation Sequencing
por: Duan, Jiali, et al.
Publicado: (2022)

1486. Missed and Delayed Diagnosis of Pneumocystis Pneumonia in HIV and Non-HIV-Infected Individuals
por: Miller, Aaron, et al.
Publicado: (2018)

Association Between the Severity of Obstructive Sleep Apnea and the Risk Stratification of Acute Pulmonary Embolism
por: Chen, Jiayue, et al.
Publicado: (2023)

The mycological and molecular study of Pneumocystis jiroveci pneumonia among HIV and non-HIV immunocompromised patients hospitalized in pulmonary units in Guilan, Northern Iran
por: Rafat, Zahra, et al.
Publicado: (2021)

Pneumocystis Pneumonia in a Non-Immunocompromised Lung Cancer Patient after Surgery: A Case Report
por: Kim, Tae-Woo, et al.
Publicado: (2022)

Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing
por: Huang, Liping, et al.
Publicado: (2023)

Pneumocystis pneumonia in children – the relevance of chemoprophylaxis in different groups of immunocompromised and immunocompetent paediatric patients
por: Zajac-Spychała, Olga, et al.
Publicado: (2015)

Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis
por: Puing, Alfredo G., et al.
Publicado: (2021)

Massive Cavitation by Pneumocystis jirovecii in an Immunocompromised Patient
por: Chaar-Hernandez, Aldair, et al.
Publicado: (2022)

Pneumonia in the Non–HIV-Infected Immunocompromised Patient
por: Quint, Jennifer, et al.
Publicado: (2012)

Lymphocyte subset analysis to evaluate the prognosis of HIV-negative patients with pneumocystis pneumonia
por: Jin, Fan, et al.
Publicado: (2021)

The Pathogenesis and Diagnosis of Pneumocystis jiroveci Pneumonia
por: Apostolopoulou, Anna, et al.
Publicado: (2022)

Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study
por: Gaborit, Benjamin Jean, et al.
Publicado: (2019)

Metagenomic Next-Generation Sequencing Is Highly Efficient in Diagnosing Pneumocystis Jirovecii Pneumonia in the Immunocompromised Patients
por: Wang, Dongsheng, et al.
Publicado: (2022)

A Case Report of Purtscher-Like Retinopathy Secondary to Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient
por: Bezzina, Alastair David, et al.
Publicado: (2022)

Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients
por: Grønseth, Stine, et al.
Publicado: (2021)

Usefulness of ß-d-Glucan Assay for the First-Line Diagnosis of Pneumocystis Pneumonia and for Discriminating between Pneumocystis Colonization and Pneumocystis Pneumonia
por: Bigot, Jeanne, et al.
Publicado: (2022)

2566. Diagnosis of Pneumocystis jiroveci Pneumonia in HIV-Negative Immunocompromised Patients: Is the Gomori-Methenamine Silver Stain of Bronchoalveolar Lavage Fluid the Gold Standard or Sub-Standard?
por: Slotkin, Rebecca, et al.
Publicado: (2018)

The diagnostic value of metagenomic next-generation sequencing for identifying Pneumocystis jirovecii infection in non-HIV immunocompromised patients
por: Zhao, Mengyi, et al.
Publicado: (2022)

Exploring the Differences in Pneumocystis Pneumonia Infection Between HIV and Non-HIV Patients
por: Nasr, Mohamed, et al.
Publicado: (2022)

Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient
por: Bhat, Pavan, et al.
Publicado: (2020)

Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients
por: Maillet, M., et al.
Publicado: (2013)

Pneumocystis Pneumonia in HIV-positive Adults, Malawi
por: van Oosterhout, Joep J.G., et al.
Publicado: (2007)

Methylprednisolone/tacrolimus: Non-HIV Pneumocystis jirovecii pneumonia: case report
Publicado: (2022)

Pneumocystis Carinii Pneumonia. Pathogenesis. Diagnosis. Treatment
por: Baltimore, Robert S.
Publicado: (1985)

Recent Advances in the Diagnosis and Management of Pneumocystis Pneumonia
por: Tasaka, Sadatomo
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hs9dn3v83rbnj13jmrnsqf12uf